Idarubicin
未知生产厂商
Idarubicin is an anthracycline antineoplastic agent used to treat acute myeloid leukemia (AML) in adults.
Idarubicin is an anthracycline antineoplastic agent used to treat acute myeloid leukemia (AML) in adults.
Idarubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Idarubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes.
For the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.
共 1 项相关疾病